Home Cellular health Amrita School of Biotechnology, University of Arizona to offer dual degree program in Life Sciences

Amrita School of Biotechnology, University of Arizona to offer dual degree program in Life Sciences

0


Amrita School of Biotechnology, Department of Cellular and Molecular Medicine, University Of Arizona, will offer a dual degree program in Life Sciences

Image credit: Amrita University

New Delhi:

The School of Biotechnology at Amrita Vishwa Vidyapeetham University has partnered with the Department of Cellular and Molecular Medicine at the University of Arizona to offer a dual degree program in Life Sciences.

Students will have the option of receiving two degrees – MSc Biotechnology, Microbiology or Bioinformatics from Amrita Vishwa Vidyapeetham and MS Cellular and Molecular Medicine from the University of Arizona, Amrita University said.





Students enrolled in this double-degree program will also be able to conduct research in the laboratories of the University of Arizona, he said.

Professor Bipin Nair, Dean of the Faculty of Science at the Amrita School of Biotechnology, said it was a strategic merger of the strengths of the two universities, both in terms of academic fervor and excellence. in research.

“We are honored to have entered into this dual degree partnership with Amrita Vishwa Vidyapeetham University … this opportunity allows us to push the boundaries of our own university by harnessing the expertise of our renowned and internationally recognized faculty. exciting is part of our larger mission to expand access to Arizona health science education in the United States and around the world, ”said Carol C. Gregorio, Head of the Department of Cellular Medicine and molecular from the University of Arizona.

Dr Maneesha Ramesh, Dean of International Programs, Amrita Vishwa Vidyapeetham said the partnership with the University of Arizona is a “strategically important step” to ensure that Amrita University students “receive the best possible education as stepping stone to a bright future.